Literature DB >> 16827890

Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis.

T Yoshioka1, I Hikita, M Asakawa, T Hirasawa, M Deguchi, T Matsutani, H Oku, T Horikawa, A Arimura.   

Abstract

Itching is one of the major clinical symptoms in atopic dermatitis (AD) and complicates the management of this pathological condition. An animal model of AD-like pruritus would contribute to a better understanding of AD and could lead to the development of safe and effective antipruritic agents. DS non-hair (DS-Nh) mice raised under conventional conditions spontaneously develop pruritus, which is associated with a dermatitis similar to human AD. There is a significant positive correlation between disease severity and the period of scratching behaviour in DS-Nh mice. In the present study, we found that levels of histamine and nerve growth factor (NGF) in serum and/or skin tissue were higher in DS-Nh mice with AD-like dermatitis than in age-matched mice without dermatitis. The histopathological data indicated that nerve fibres extend into and mast cells infiltrate the surrounding area of the skin lesion. NGF production by XB-2 cells, which was derived from mouse keratinocytes, was enhanced by histamine via the H1 receptor. We also found that prolonged treatment with an H1-antagonist was effective against pruritus through depression of the production of NGF, which is thought to be generated by keratinocytes. We conclude that DS-Nh mice can serve as a suitable model for gaining a better understanding of pruritus in AD, and that prolonged treatment with an H1-antagonist may be beneficial in patients with AD-associated pruritus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827890      PMCID: PMC1782295          DOI: 10.1111/j.1365-2567.2006.02365.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis.

Authors:  C F Wahlgren; O Hägermark; R Bergström
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

2.  Failure of terfenadine in relieving the pruritus of atopic dermatitis.

Authors:  J Berth-Jones; R A Graham-Brown
Journal:  Br J Dermatol       Date:  1989-11       Impact factor: 9.302

3.  The 'butterfly' sign in patients with atopic dermatitis: evidence for the role of scratching in the development of skin manifestations.

Authors:  T Kimura; H Miyazawa
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

Review 4.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

5.  Plasma histamine concentrations in atopic eczema.

Authors:  J Ring
Journal:  Clin Allergy       Date:  1983-11

6.  DS-Nh as an experimental model of atopic dermatitis induced by Staphylococcus aureus producing staphylococcal enterotoxin C.

Authors:  T Yoshioka; I Hikita; T Matsutani; R Yoshida; M Asakawa; T Toyosaki-Maeda; T Hirasawa; R Suzuki; A Arimura; T Horikawa
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 7.  Animal models for atopic dermatitis: are they relevant to human disease?

Authors:  Tetsuo Shiohara; Jun Hayakawa; Yoshiko Mizukawa
Journal:  J Dermatol Sci       Date:  2004-10       Impact factor: 4.563

8.  Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome.

Authors:  T Ruzicka; S Glück
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

9.  Prevalence of and risk factors for allergic diseases: comparison of two cities in Japan.

Authors:  T Hayashi; N Kawakami; N Kondo; H Agata; O Fukutomi; H Shimizu; T Orii
Journal:  Ann Allergy Asthma Immunol       Date:  1995-12       Impact factor: 6.347

10.  Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones.

Authors:  P B Ehrhard; P Erb; U Graumann; U Otten
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  6 in total

1.  PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.

Authors:  Jiahui Zhao; Admire Munanairi; Xian-Yu Liu; Jie Zhang; Linghan Hu; Meiqin Hu; Dingfang Bu; Lingling Liu; Zhiqiang Xie; Brian S Kim; Yong Yang; Zhou-Feng Chen
Journal:  J Invest Dermatol       Date:  2020-01-29       Impact factor: 8.551

2.  Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.

Authors:  Takeshi Yoshioka; Kinichi Imura; Ichiro Hikita; Tsutomu Hirasawa; Tsuneaki Sakata; Takaji Matsutani; Tatsuya Horikawa; Akinori Arimura
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

3.  A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.

Authors:  Zenro Ikezawa; Junko Komori; Yuko Ikezawa; Yusuke Inoue; Mio Kirino; Masako Katsuyama; Michiko Aihara
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-12       Impact factor: 5.764

4.  Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus.

Authors:  Hang Qi; Yuntao Shi; Han Wu; Canyang Niu; Xiaoying Sun; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-05       Impact factor: 11.413

5.  Role of TRPV3 in immune response to development of dermatitis.

Authors:  Kinichi Imura; Takeshi Yoshioka; Tsutomu Hirasawa; Tsuneaki Sakata
Journal:  J Inflamm (Lond)       Date:  2009-05-25       Impact factor: 4.981

Review 6.  Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?

Authors:  Neide Kalil Gaspar; Márcia Kalil Aidé
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.